Your browser doesn't support javascript.
loading
Virus reduction neutralization test and LI-COR microneutralization assay bridging and WHO international standard calibration studies for respiratory syncytial virus.
Sun, Dengyun; Homan, Ying X; Antonello, Joseph M; Giacone, Danila; Bogardus, Leah; Zhang, Yuhua; Feng, Wen; Caro-Aguilar, Ivette C; Hsu, Amy; Dellatore, Shara; Whiteman, Melissa C.
Afiliação
  • Sun D; Analytical Research & Development, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, NJ 07065, USA.
  • Homan YX; Regulated Bioanalytical Immunogenicity & Molecular, Preclinical Development, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, NJ 07065, USA.
  • Antonello JM; Biometrics Research, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, NJ 07065, USA.
  • Giacone D; Analytical Research & Development, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, NJ 07065, USA.
  • Bogardus L; Analytical Research & Development, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, NJ 07065, USA.
  • Zhang Y; Current address: Project & Portfolio Management, Pfizer Inc. 235 E 42nd Street, New York, NY 10017, USA.
  • Feng W; Biometrics Research, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, NJ 07065, USA.
  • Caro-Aguilar IC; Regulated Bioanalytical Immunogenicity & Molecular, Preclinical Development, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, NJ 07065, USA.
  • Hsu A; Regulated Bioanalytical Immunogenicity & Molecular, Preclinical Development, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, NJ 07065, USA.
  • Dellatore S; Analytical Research & Development, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, NJ 07065, USA.
  • Whiteman MC; Analytical Research & Development, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, NJ 07065, USA.
Bioanalysis ; 14(15): 1067-1079, 2022 Aug.
Article em En | MEDLINE | ID: mdl-36125040
ABSTRACT

Background:

Respiratory syncytial virus (RSV) vaccine is an unmet medical need. The virus reduction neutralization test (VRNT) was developed to replace the LI-COR microneutralization assay to measure RSV neutralization titers.

Methods:

A bridging study using selected V171 phase I samples and calibration studies using the WHO international standard antiserum to RSV were performed to compare VRNT and LI-COR.

Results:

From the bridging study, we showed good concordance between VRNT and LI-COR titers, and similar post-/prevaccination titer ratios. From the calibration studies, we can convert VRNT and LI-COR titers into similar IU/ml.

Conclusion:

The VRNT and LI-COR microneutralization assay correlate well and the titers can be standardized as similar IU/ml, enabling direct comparison of titers from different assays.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus Sinciciais Respiratórios / Vacinas Tipo de estudo: Prognostic_studies Idioma: En Revista: Bioanalysis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus Sinciciais Respiratórios / Vacinas Tipo de estudo: Prognostic_studies Idioma: En Revista: Bioanalysis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos